Van Oene Mark's most recent trade in Pacific Biosciences of California Inc was a trade of 898,352 Stock Option (right to buy) done . Disclosure was reported to the exchange on March 19, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Pacific Biosciences of Cal...
|
Oene Mark Van | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2025 | 898,352 | 898,352 | - | - | Stock Option (right to buy) | |
Pacific Biosciences of Cal...
|
Oene Mark Van | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2025 | 449,176 | 1,946,871 (1%) | 0% | 0 | Common Stock | |
Pacific Biosciences of Cal...
|
Oene Mark Van | See Remarks | Sale of securities on an exchange or to another person at price $ 1.41 per share. | 03 Mar 2025 | 6,486 | 1,497,695 (0%) | 0% | 1.4 | 9,126 | Common Stock |
Pacific Biosciences of Cal...
|
Oene Mark Van | See Remarks | Sale of securities on an exchange or to another person at price $ 1.88 per share. | 18 Feb 2025 | 100,773 | 1,496,681 (0%) | 0% | 1.9 | 189,252 | Common Stock |
Pacific Biosciences of Cal...
|
Oene Mark Van | See Remarks | Sale of securities on an exchange or to another person at price $ 2.03 per share. | 10 Jan 2025 | 34,405 | 1,597,454 (1%) | 0% | 2.0 | 69,980 | Common Stock |
Pacific Biosciences of Cal...
|
Oene Mark Van | See Remarks | Sale of securities on an exchange or to another person at price $ 1.66 per share. | 16 Aug 2024 | 38,011 | 1,630,815 (1%) | 0% | 1.7 | 63,174 | Common Stock |
Pacific Biosciences of Cal...
|
Oene Mark Van | See Remarks | Sale of securities on an exchange or to another person at price $ 4.87 per share. | 04 Mar 2024 | 9,186 | 1,668,826 (1%) | 0% | 4.9 | 44,745 | Common Stock |
Pacific Biosciences of Cal...
|
Van Mark Oene | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 798,076 | 1,674,687 (1%) | 0% | 0 | Common Stock | |
Pacific Biosciences of Cal...
|
Oene Van Mark | See Remarks | Sale of securities on an exchange or to another person at price $ 5.96 per share. | 16 Feb 2024 | 33,560 | 876,611 (0%) | 0% | 6.0 | 199,950 | Common Stock |
Pacific Biosciences of Cal...
|
Van Oene Mark | See Remarks | Sale of securities on an exchange or to another person at price $ 7.77 per share. | 09 Jan 2024 | 31,012 | 910,171 (0%) | 0% | 7.8 | 241,056 | Common Stock |
Pacific Biosciences of Cal...
|
Mark Oene Van | See Remarks | Sale of securities on an exchange or to another person at price $ 11.00 per share. | 16 Aug 2023 | 26,102 | 939,769 (0%) | 0% | 11 | 287,122 | Common Stock |
Pacific Biosciences of Cal...
|
Mark Oene Van | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 328,500 | 972,139 (0%) | 0% | 0 | Common Stock | |
Pacific Biosciences of Cal...
|
Van Mark Oene | See Remarks | Sale of securities on an exchange or to another person at price $ 9.49 per share. | 02 Mar 2023 | 6,268 | 965,871 (0%) | 0% | 9.5 | 59,502 | Common Stock |
Pacific Biosciences of Cal...
|
Mark Van Oene | See Remarks | Sale of securities on an exchange or to another person at price $ 9.53 per share. | 10 Jan 2023 | 26,722 | 640,808 (0%) | 0% | 9.5 | 254,768 | Common Stock |
Illumina Inc
Board Appointment |
Oene Mark Van | SVP Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 311.72 per share. | 05 Nov 2020 | 1,073 | 16,575 (0%) | 0% | 311.7 | 334,476 | Common Stock |
Illumina Inc
Board Appointment |
Oene Mark Van | SVP Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 355.04 per share. | 01 Sep 2020 | 585 | 17,688 (0%) | 0% | 355.0 | 207,698 | Common Stock |
Illumina Inc
Board Appointment |
Oene Mark Van | SVP Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 356.38 per share. | 01 Sep 2020 | 40 | 17,648 (0%) | 0% | 356.4 | 14,255 | Common Stock |
Illumina Inc
Board Appointment |
Oene Mark Van | SVP Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 385.43 per share. | 03 Aug 2020 | 625 | 18,255 (0%) | 0% | 385.4 | 240,894 | Common Stock |
Illumina Inc
Board Appointment |
Oene Mark Van | SVP Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 370.10 per share. | 01 Jul 2020 | 400 | 18,880 (0%) | 0% | 370.1 | 148,040 | Common Stock |
Illumina Inc
Board Appointment |
Oene Mark Van | SVP Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 367.68 per share. | 01 Jul 2020 | 125 | 19,380 (0%) | 0% | 367.7 | 45,960 | Common Stock |
Illumina Inc
Board Appointment |
Oene Mark Van | SVP Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 368.74 per share. | 01 Jul 2020 | 100 | 19,280 (0%) | 0% | 368.7 | 36,874 | Common Stock |
Illumina Inc
Board Appointment |
Oene Mark Van | SVP Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 361.44 per share. | 01 Jun 2020 | 525 | 19,605 (0%) | 0% | 361.4 | 189,756 | Common Stock |
Illumina Inc
Board Appointment |
Oene Mark Van | SVP Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 362.07 per share. | 01 Jun 2020 | 100 | 19,505 (0%) | 0% | 362.1 | 36,207 | Common Stock |
Illumina Inc
Board Appointment |
Oene Mark Van | SVP Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 316.82 per share. | 01 May 2020 | 525 | 20,230 (0%) | 0% | 316.8 | 166,331 | Common Stock |
Illumina Inc
Board Appointment |
Oene Mark Van | SVP Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 316.86 per share. | 01 May 2020 | 100 | 20,130 (0%) | 0% | 316.9 | 31,686 | Common Stock |
Illumina Inc
Board Appointment |
Oene Mark Van | SVP Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 300.22 per share. | 16 Apr 2020 | 1,250 | 20,755 (0%) | 0% | 300.2 | 375,275 | Common Stock |